PLK
Catalog No. | Inhibitor Name | PLK1 | PLK2 | PLK3 | Other |
---|---|---|---|---|---|
A10134 | BI 2536 | **** | ** | ** | PI3Kα,Met,Tie-2 |
A10135 | Volasertib | **** | |||
A10673 | Rigosertib | ** | |||
A10442 | GSK461364 | *** | |||
A12429 | MLN0905 | *** | |||
A13245 | Ro3280 | ** | |||
A14426 | SBE 13 HCl | **** | * | ||
A13045 | NMS-P937 | *** | |||
A10452 | HMN-214 | ||||
A11146 | TAK-960 | **** | ** | * | |
A11438 | GW843682X | *** | ** |
Notes:
1.Hover mouse over " " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
-
BI6727 (Volasertib)
Catalog No. A10135 PLK 抑制剂BI6727 (Volasertib)是一种高效且选择性的polo样激酶(PLK)1抑制剂(在一组癌细胞系中,酶IC50 = 0.87 nM,EC50 = 11-37 nM)。 了解更多 -
HMN-214
Catalog No. A10452 -
TAK-960
Catalog No. A11146 -
ON-01910 (rigosertib)
Catalog No. A10673 PLK 抑制剂ON-01910 (rigosertib)通过涉及PI3K/AKT抑制和氧化应激诱导的双重作用机制对慢性淋巴细胞白血病细胞具有选择性的细胞毒性。 了解更多 -
MLN 0905
Catalog No. A12429 -
NMS-1286937
Catalog No. A13045 -
SBE 13 HCl
Catalog No. A14426 PLK 抑制剂SBE 13 HCl是PLK1的选择性抑制剂,对于PLK1,PLK3和PLK2,IC 50值分别为200pM,875nM和66μM。 了解更多 -
LFM-A13
Catalog No. A16261 -
AAPK-25
Catalog No. A19085 Aurora/PLK dual 抑制剂AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3Ser10 phosphorylation and followed by a surge in apoptosis. 了解更多